Kala BIO, Inc. (KALA) intrinsic value & 10-year financials
Kala BIO, Inc. (KALA) has a Graham intrinsic value of $54.49 per share. At $0.19 on Oct 17, 2026, the stock trades 100% below that value. Over the last 10 fiscal years revenue shrank 13.8% a year to $0, with an average return on invested capital of 488.3%.
- Graham intrinsic value
- $54.49
- Share price (Oct 17, 2026)
- $0.19
- Price vs Graham value
- 100% below
- Market cap
- $1.5M
- Revenue (FY2025)
- $0
- Revenue growth (10-yr CAGR)
- -13.8%
- ROIC (10-yr avg)
- 488.3%
- Free cash flow (FY2025)
- —
KALA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $0 | -$27.0M | -$3.31 | — | — | 561.3% |
| FY2024 | $0 | -$38.5M | -$10.15 | — | — | 570.0% |
| FY2023 | $0 | -$42.2M | -$17.35 | — | — | 496.2% |
| FY2022 | $3.9M | -$44.8M | -$29.48 | — | -2099.3% | 4199.7% |
| FY2021 | $11.2M | -$142.6M | -$2.19 | — | -1158.8% | -205.4% |
| FY2020 | $6.4M | -$104.3M | -$1.99 | — | -1512.6% | -115.8% |
| FY2019 | $6.1M | -$94.3M | — | -$94.1M | -1452.5% | -228.7% |
| FY2018 | — | -$66.7M | — | -$55.7M | — | -482.5% |
| FY2017 | $0 | -$42.2M | — | -$34.6M | — | 61.4% |
| FY2016 | $0 | -$33.2M | — | -$27.5M | — | 26.4% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
KALA BIO, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
KALA BIO, Inc. has historically struggled to out-earn its cost of capital, averaging just 2.1% ROIC.
KALA BIO, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, KALA BIO, Inc. is modeled at -13.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $54.49 per share.